Medium Ring-Nitrogen Heterocycles
FULL PAPER
J=16.2, 8.7 Hz, 1H, NCHH), 3.94–4.12 (m, 2H, NCHH, NCH), 5.02–
5.12 (m, 2H, CH=CH2), 6.04 (m, 1H, CH=CH2), 6.32 (d, J=14.8 Hz, 1H,
CH=CHS), 6.70 (dd, J=14.8, 10.9 Hz, 1H, CH=CHS), 7.60–7.75 (m, 3H,
Ph), 7.98–8.01 ppm (m, 2H, Ph);13C NMR (100 MHz, CDCl3): d=À5.5
(d), À5.4 (d), 17.3 (d), 18.4 (u), 21.3 (d), 25.1 (d), 26.0 (d), 27.5 (d), 29.6
(d), 49.6 (d), 60.9 (u), 62.6 (u), 63.9 (u), 116.6 (u), 128.4 (u), 129.3 (d),
132.1 (d), 132.6 (d), 137.7 (d), 139.2 (u), 144.4 ppm (d); IR (KBr): n=
2958 (s), 1628 (w), 1467 (m), 1317 (s), 1249 (s), 1118 (s), 836 cmÀ1 (m);
MS (EI, 70 eV): m/z (%): 571 [M ++1] (1.95), 513 (5), 449 (12), 238 (36),
237 (38), 214 (100), 155 (35), 57 (26); MS (CI, CH4): m/z (%): 571 [M+
+1] (100), 449 (11), 214 (15); HRMS (EI, 70 eV): m/z: calcd for
C24H41N2O4S2Si: 513.22770; found: 513.22773 [M +ÀC4H9].
Having demonstrated the feasibility of a reductive remov-
al of the sulfoximine group of a MRNH of type II, the de-
protection of the N-atom of II (PG1 =tBuSO2) was probed
with the MRNH 20. Treatment of sulfonamide 20 with
[12a,19]
CF3SO3H in CH2Cl2
led to a cleavage of both then N-
and O-protecting group and gave the amino alcohol 34 in
86% yield.[31]
Conclusion
N-Allyl-N-((2S,3R,6R,E)-1-(tert-butyldimethylsilyloxy)-6-hydroxy-3-iso-
propyl-5-((S)-N-methyl-S-phenylsulfonimidoyl)deca-4,9-dien-2-yl)-2-
methylpropane-2-sulfonamide (16a) and N-allyl-N-((2S,3R,6S,E)-1-(tert-
butyldimethylsilyloxy)-6-hydroxy-3-isopropyl-5-((S)-N-methyl-S-phenyl-
sulfonimidoyl)deca-4,9-dien-2-yl)-2-methylpropane-2-sulfonamide (16b):
To a solution of alkenylsulfoximine 8 (100 mg, 0.175 mmol) in THF
(3 mL) at À788C was added nBuLi (109 mL, 1.6m solution in n-hexane,
0.175 mmol). After the mixture was stirred for 15 min, a solution of pent-
4-enal (17 mg, 0.202 mmol) in THF (1 mL) was added dropwise. Then
the mixture was stirred for 20 min, after which time the conversion of Li-
8 was complete. Then the mixture was quenched through addition of sa-
turated aqueous NH4Cl and extracted with EtOAc. The combined organ-
ic phases were dried (MgSO4) and concentrated in vacuo. Purification by
The Ru-catalyzed RCM reaction of the sulfoximine-substi-
tuted sterically hindered N-tethered 1,7,10-, 1,7,11- and
1,7,12-trienes, for which a modular asymmetric synthesis was
developed, gave the corresponding nine-, ten- and eleven-
membered MRNHs. The MRNHs of type II contain func-
tional groups that should make them useful synthetic build-
ing blocks. Also bicyclic MRNHs of type II could be accessi-
ble in which R1 and R2 and the adjacent C-atoms are em-
bedded in a five–seven-membered ring since the corre-
sponding homoallylic amines X in are readily available.[12] It
seems noteworthy that the Lewis basic sulfoximine group of
the N-tethered trienes generally does not require a protec-
tion like most amines in RCM reactions.[3f,4d,27] The feasibili-
ty of an efficient removal of both the chiral auxiliary and
the N-protecting group was demonstrated for a MRNH. The
synthesis of MRHNHs II, carbocycles VII and lactones IX
demonstrates the applicability of the modular sulfoximine-
RCM-route to sulfoximine-substituted medium-sized rings.
The key steps of this route are 1) the diastereoselective hy-
droxy- and aminoalkylation of sulfoximine-substituted allyl-
titanium complexes with unsaturated aldehydes and N-sulfo-
nylimino esters, respectively, 2) the synthesis of trienes via
alkylation of a-lithioalkenylsulfoximines, and 3) the Ru-cat-
alyzed RCM reaction of the trienes. The facile Ru-catalyzed
RCM of the highly substituted trienes I, VI and VIII with
formation of the corresponding heterocycles and carbocycles
once more demonstrates the power of this method for the
synthesis of medium-sized rings.
flash chromatography (n-hexane/EtOAc 8:2) gave
a 7:3 mixture
(1H NMR: NMe) of the diastereomeric alcohols 16a/b (100 mg, 87%).
HPLC (n-hexane/EtOAc 85:15) afforded alcohol 16a (65 mg, 53%) and
alcohol 16b (32 mg, 28%) as viscous liquids. 16a: [a]D =À13.6 (c=0.55
in CHCl3); Rf =0.75 (n-hexane/EtOAc 8:2); 1H NMR (400 MHz, CDCl3,
558C): d=0.00 (s, 3H, SiCH3), 0.01 (s, 3H, SiCH3), 0.86 (s including a
doublet, J=6.6 Hz, 12H, SiC
CH3CH), 1.44 (s, including a merged m, 10H, SiC
1.80–2.00 (m, 2H, CHHCHOH, CHHCH2CHOH), 2.10–2.22 (m, 1H,
CHHCH2CHOH), 2.33 (app septd, J=6.3, 2.4 Hz, 1H, CH(CH3)3), 2.81
(s, including a merged bt, 4H, NCH3, CH(CH3)3), 3.41 (dd, J=11.2,
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
AHCTUNGTRENNUNG
AHCTUNGTRENNUNG
4.6 Hz, 1H, CHHO), 3.52 (t, J=10.7 Hz, 1H, CHHO), 3.71 (dd, J=16.4,
9.07 Hz, 1H, NCHH), 3.89 (bs, 1H, CHN), 4.12 (dd, J=16.2, 2.4 Hz, 1H,
NCHH), 4.50 (dd, J=8.8, 3.02 Hz, 1H, CHOH), 4.95 (ddd, J=17.0, 9.6,
1.3 Hz, 2H, CH2CH2CH=CH2), 5.12 (dd, J=16.3, 10.4 Hz, 2H,
NCH2CH=CH2), 5.50 (brs, 1H, OH), 5.62–5.76 (m, 1H, CH2CH2CH=
CH2), 5.87–6.10 (m, 1H, NCH2CH=CH2), 6.51 (d, J=11.5 Hz, 1H, CH=
CS), 7.50–7.60 (m, 3H, Ph), 7.90 ppm (dd, J=6.8, 1.65 Hz, 2H, Ph);
13C NMR (100 MHz, CDCl3): d=À5.2 (d), À4.9 (d), 16.7 (d),18.7 (u),
21.1 (u), 25.1 (d), 26.2 (d), 28.4 (d), 29.4 (d), 30.7 (u), 36.6 (u), 45.1 (d),
48.9 (u), 61.0 (d), 63.0 (u), 63.3 (u), 69.1 (d), 115.1 (u), 116.2 (u), 128.6
(d), 129.4 (d), 132.6 (d), 137.2 (d), 138.5 (d), 140.5 (u), 142.1 (d),
143.7 ppm (u); IR (KBr): n=3453 (w), 3290 (w), 2956 (s), 1639 (w), 1464
(m), 1318 (s), 1245 (s), 1118 (s), 846 cmÀ1 (s); MS (EI, 70 eV): m/z (%):
655 [M + +1] (3), 597 (3), 214 (39.8), 156 (34), 125 (20), 57 (100); MS
(CI, CH4): m/z (%): 655 [M + +1] (100), 597 (10), 378 (11), 214 (26), 156
(14); HRMS (EI, 70 eV): m/z: calcd for C33H59N2O5S2Si: 655.36347;
found: 655.36025 [M + +H]. 16b: [a]D =+36.6 (c=1.0 in CHCl3); Rf =
Experimental Section
N-Allyl-N-((2S,3R,E)-1-(tert-butyldimethylsilyloxy)-3-isopropyl-5-((S)-N-
methyl-S-phenylsulfonimidoyl)pent-4-en-2-yl)-2-methylpropane-2-sulfo-
1
0.75 (n-hexane/EtOAc 8:2); H NMR (400 MHz, CDCl3): d=0.00 (s, 6H,
Si
CH3CH), 0.85 (s, 9H, SiC
1H, CHHCHOH), 1.99 (oct, J=7.6 Hz, 1H, CHHCH2CHOH), 2.12–2.23
(m, 3H, CHHCH2CHOH, CHHCHOH, CH(CH3)2), 2.64 (s, 3H, NCH3),
2.71 (t, J=4.6 Hz, 1H, CHCH(CH3)2), 3.42–3.53 (m, 2H, CH2OSi), 3.69–
3.75 (m, 2H, NCH, NCHH), 4.00 (dd, J=16.4, 1.92 Hz, 1H, NCHH),
4.40 (d, J=7.9 Hz, 1H, CHOH), 4.85 (brs, 1H, OH), 4.95 (ddd, J=17.3,
10.7, 1.37 Hz, 2H, CH2CH2CH=CH2), 5.10 (dd, J=17.3, 10.1 Hz, 2H,
NCH2CH=CH2), 5.62–5.70 (m, 1H, CH2CH2CH=CH2), 5.85–5.96 (m, 1H,
NCH2CH=CH2), 6.04 (d, J=11.8 Hz, 1H, CH=CS), 7.46–7.56 (m, 3H,
Ph), 7.80 ppm (d, J=7.4 Hz, 2H, Ph); 13C NMR (100 MHz, CDCl3): d=
À5.0 (d), 17.5 (d),18.7 (u), 21.8 (d), 25.1 (d), 26.2 (d), 28.2 (d), 29.4 (d),
30.5 (u), 36.0 (u), 45.6 (d), 48.9 (u), 60.9 (d), 62.9 (u), 63.0 (u), 69.1 (d),
115.2 (u), 116.7 (u), 128.7 (d), 129.3 (d), 132.9 (d), 137.6 (d), 138.0 (d);
139.0 (u), 140.3 (d), 145.5 ppm (u); IR (KBr): n = 3492 (m), 2956 (s),
ACHTUNGTRENNUNG
namide (8): To
a solution of a mixture of alcohols 7a/b (420 mg,
G
ACHTUNGTRENNUNG
0.742 mmol) and imidazole (252 mg, 3.70 mmol) in DMF (4 mL) at 08C
was added tBuMe2SiCl (222 mg, 1.48 mmol). The mixture was stirred first
at 08C for 30 min and then at room temperature for 4 h. After the com-
plete consumption of alcohols 7a/b (TLC), the mixture was heated at
1008C for 4 h. Then the mixture was diluted with EtOAc and washed
with water (3ꢁ10 mL). The organic layer was washed with brine and
dried (MgSO4). Concentration in vacuo and purification by column chro-
matography (n-hexane/EtOAc 8:2) gave the silyl ethers 8a/b (331 mg,
78%) as a colorless oil. [a]D =À2.6 (c=1.05 in CH2Cl2); Rf =0.47 (n-
hexane/EtOAc 7:3); 1H NMR (400 MHz, CDCl3): d=0.01 (s, 3H,
AHCTUNGTRENNUNG
AHCTUNGTRENNUNG
SiCH3), 0.08 (s, 3H, SiCH3), 0.93 (s, 9H, SiC
3H, CH3CH), 1.00 (d, J=6.9 Hz, 3H, CH3CH), 1.51 (s, 9H, SC
2.34 (app septd, J=6.5, 2.1 Hz, 1H, CH(CH3)2), 2.63 (t, J=9.9 Hz, 1H,
CHCH(CH3)2), 2.87 (s, 3H, NCH3), 3.58–3.73 (m, 2H, CH2O), 3.90 (dd,
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
AHCTUNGTRENNUNG
ACHTUNGTRENNUNG
Chem. Eur. J. 2011, 17, 6187 – 6195
ꢀ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
6193